Simplify Asset Management »

Sage Therapeutics shares owned by Simplify Asset Management

Quarter-by-quarter ownership of Sage Therapeutics (SAGE) shares owned by Simplify Asset Management from 13F filings

Historical chart of Simplify Asset Management investment in Sage Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sage Therapeutics held by Simplify Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sage Therapeutics by Simplify Asset Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $2.5M 120k 20.58
2023-06-30 $2.4M 50k 47.02
2023-03-31 $2.1M 50k 41.96

More positions owned by Simplify Asset Management

Ishares Tr 20 Yr Tr Bd Etf Put Option (TLT)
Ishares Tr Core S&p500 Etf (IVV)
Simplify Exchange Traded Fun Aggregate Bond E (AGGH)
Ishares Tr Iboxx Inv Cp Etf Call Option (LQD)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Simplify Exchange Traded Fun Stable Incm Etf (BUCK)
Plains Gp Hldgs Ltd Partnr Int A (PAGP)
Pimco Etf Tr 15+ Yr Us Tips (LTPZ)
Tesla Motors Call Option (TSLA)
Applied Therapeutics (APLT)
Ishares Tr Core Us Aggbd Et (AGG)
Simplify Exchange Traded Fun Short Term Trea (TUA)
Ishares Tr Mbs Etf (MBB)
Tscan Therapeutics (TCRX)
Simplify Exchange Traded Fun High Yield Plus (CDX)

View all positions for Simplify Asset Management

Top funds holding Sage Therapeutics

Wellington Management Company
Vanguard Group
Bellevue Group
Jpmorgan Chase & Co
Cowen And Company
Deutsche Bank Aktiengesellschaft
Palo Alto Investors
Dimensional Fund Advisors
Samlyn Capital
Jacobs Levy Equity Management
Citadel Advisors
T. Rowe Price Associates
Goldman Sachs Group
Fisher Investments
Charles Schwab Investment Management

View all funds holding Sage Therapeutics